Diamantis Christopher Eric 4
4 · Rennova Health, Inc. · Filed Sep 27, 2021
Insider Transaction Report
Form 4
Diamantis Christopher Eric
Director
Transactions
- Other
Common Stock
2021-08-27+95,000,000→ 95,450,000 total - Other
Series M Convertible Redeemable Preferred Stock
2021-08-27−570→ 20,180 total→ Common Stock - Other
Warrants to Purchase Common Stock
2021-08-27+47,500,000→ 47,500,000 totalExercise: $0.01From: 2021-08-27Exp: 2024-08-27→ Common Stock (47,500,000 underlying)
Footnotes (3)
- [F1]On August 27, 2021, pursuant to the terms of an Exchange Agreement with the Issuer, Mr. Diamantis exchanged 570 shares of Series M Redeemable Convertible Preferred Stock of the Issuer (the "Series M Preferred Stock") for 95,000,000 shares of Common Stock and Warrants to purchase 47,500,000 shares of Common Stock.
- [F2]The exercise of the Warrants and the conversion of the Series M Preferred Stock are each subject to ownership blockers of 4.99%. As a result, they are not exercisable or convertible as of August 27, 2021. The Series M Preferred Stock has no stated maturity date.
- [F3]The conversion price of the Series M Preferred Stock fluctuates with the price of the Common Stock.